Kate Hanrott

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study

Valerie J. Ludbrook, Kirsty Hicks, Kate Hanrott et al. · British Journal of Dermatology · 2016 · 85 citations

Medicine, Dermatology, Pharmacology +13

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

Jatin Patel, Damon Bass, Albertus Beishuizen et al. · European Respiratory Journal · 2022 · 42 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough

Valerie J. Ludbrook, Kate Hanrott, James L. Kreindler et al. · ERJ Open Research · 2021 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A Randomized Trial of Otilimab in Severe COVID-19 Pneumonia (OSCAR)

Jatin Patel, Albertus Beishuizen, Xavier Bocca Ruiz et al. · medRxiv · 2021 · 27 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +15

An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension

Marc A. Simon, Kate Hanrott, David C. Budd et al. · Pulmonary Circulation · 2021 · 15 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17